Boston, MA, United States of America

Benjamin Seiler

USPTO Granted Patents = 2 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Benjamin Seiler in Pathogen Vaccines

Introduction

Benjamin Seiler is an accomplished inventor based in Boston, MA. He has made significant contributions to the field of vaccine development, particularly in the area of pathogen vaccines. With a total of two patents to his name, Seiler's work focuses on innovative methods for producing and utilizing vaccine compositions.

Latest Patents

Seiler's latest patents revolve around pathogen vaccines and methods of producing and using the same. These inventions provide vaccine compositions and outline methods for producing such compositions. They also include various embodiments for treating pathogen infections, vaccinating subjects against these infections, and addressing antibiotic-resistant bacterial infections. Furthermore, his patents detail methods for decreasing pathogen levels in infected subjects, increasing survival rates, and reducing pain and distress associated with pathogen infections. Novel scaffold compositions and opsonin-bound or lectin-bound pathogen compositions are also part of his innovative work.

Career Highlights

Seiler is affiliated with Harvard College, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on public health and the treatment of infectious diseases.

Collaborations

Seiler collaborates with notable colleagues, including Michael Super and Edward J Doherty. Their combined expertise contributes to the advancement of vaccine technology and the exploration of new treatment methodologies.

Conclusion

Benjamin Seiler's innovative work in pathogen vaccines showcases his commitment to improving health outcomes through scientific research. His contributions are vital in the ongoing battle against infectious diseases and antibiotic resistance.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…